NASDAQ:ALEC
Alector Inc. Stock News
$5.44
-0.0500 (-0.91%)
At Close: May 17, 2024
Analysts Estimate Alector (ALEC) to Report a Decline in Earnings: What to Look Out for
04:47pm, Tuesday, 03'rd Aug 2021
Alector (ALEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Alector Stock Falls After Flashing 12-Month Data From Mid-Stage Trial In Frontotemporal Dementia Patients
01:52pm, Thursday, 29'th Jul 2021
Alector Inc (NASDAQ: ALEC) detailed early data from its lead drug, AL001, INFRONT-2 Phase trial at the Alzheimer's Association International Conference (AAIC 2021) Patients with one type of frontot
AL001 Successfully Restored Progranulin to Normal Levels in FTD-GRN Patients
Oral Presentation to Highlight Data from the Ongoing Phase 2 Study of AL001 in FTD-GRN Company to Host Analyst and Investor Conference Call on July 29 at 1:00 p.m. ET
Alector's (ALEC) Shares March Higher, Can It Continue?
08:30am, Monday, 12'th Jul 2021
As of late, it has definitely been a great time to be an investor in Alector, Inc. (ALEC).
Why Alector Zoomed 12% Higher Today
05:49pm, Tuesday, 06'th Jul 2021
The company has yet another fine July trading day thanks to a Citigroup analyst.
Glaxo (GSK)/Alector Ink Deal for Neurodegenerative Indications
11:16am, Monday, 05'th Jul 2021
Glaxo (GSK) and Alector set to co-develop and co-commercialize AL001 and AL101 for neurodegenerative diseases. Glaxo issues a formal response to activist hedge investor, Elliott's call for board chang
Alector (ALEC) Up on Tie-Up With Glaxo for Neurological Diseases
11:16am, Monday, 05'th Jul 2021
Alector (ALEC) signs a global collaboration deal with Glaxo to co-develop/commercialize two monoclonal antibodies - AL001 and AL101 ??? for treating various neurodegenerative diseases.
Alector (ALEC) Stock Jumps 57.1%: Will It Continue to Soar?
09:01am, Monday, 05'th Jul 2021
Alector (ALEC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Why Alector Blasted Higher Today
02:54pm, Friday, 02'nd Jul 2021
It's not every day that a small biotech announces a major collaboration deal with a deep-pocketed pharmaceutical giant.
Don't Miss What Sent These 2 Little-Known Nasdaq Newsmakers Soaring
01:38pm, Friday, 02'nd Jul 2021
One of these companies is making big waves.
ALEC Stock: 12 Things to Know About Alector as GSK News Sends It Rocketing Higher
11:09am, Friday, 02'nd Jul 2021
Alector (ALEC) stock is rocketing higher on Friday after the biotechnology company announced a partnership with GlaxoSmithKline (GSK). The post ALEC Stock: 12 Things to Know About Alector as GSK News
Alector Shares Jump On $2.2B Immuno-Neurology Development Pact With GSK
08:26am, Friday, 02'nd Jul 2021
Alector Inc (NASDAQ: ALEC) and GlaxoSmithKline plc (NYSE: GSK) have announced a global collaboration for the development and commercialization of two monoclonal antibodies designed to elevate pro
SOUTH SAN FRANCISCO, Calif. and LONDON, July 02, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC) and GlaxoSmithKline plc (LSE/NYSE: GSK), today announced a strategic global collaboration for the
Alector to Present at Upcoming Virtual Healthcare Conferences
04:05pm, Thursday, 03'rd Jun 2021
SOUTH SAN FRANCISCO, Calif., June 03, 2021 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced that Shehnaaz Suliman,
